MA21560A1 - Nouvelles compositions comprenant des enzymes polymerises. - Google Patents

Nouvelles compositions comprenant des enzymes polymerises.

Info

Publication number
MA21560A1
MA21560A1 MA21811A MA21811A MA21560A1 MA 21560 A1 MA21560 A1 MA 21560A1 MA 21811 A MA21811 A MA 21811A MA 21811 A MA21811 A MA 21811A MA 21560 A1 MA21560 A1 MA 21560A1
Authority
MA
Morocco
Prior art keywords
novel compositions
composition
disclosed
enzymes
forms
Prior art date
Application number
MA21811A
Other languages
English (en)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of MA21560A1 publication Critical patent/MA21560A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
MA21811A 1988-05-26 1989-05-24 Nouvelles compositions comprenant des enzymes polymerises. MA21560A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (fr) 1988-05-26 1988-05-26 Compose antiviral ou antibacterien et procede d'utilisation
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
MA21560A1 true MA21560A1 (fr) 1989-12-31

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
MA21811A MA21560A1 (fr) 1988-05-26 1989-05-24 Nouvelles compositions comprenant des enzymes polymerises.

Country Status (23)

Country Link
US (3) US5200182A (fr)
EP (1) EP0380484B1 (fr)
JP (1) JPH0649659B2 (fr)
AT (1) ATE93143T1 (fr)
AU (1) AU624331B2 (fr)
BG (1) BG60544B1 (fr)
CA (1) CA1335425C (fr)
CS (1) CS277030B6 (fr)
DK (1) DK173078B1 (fr)
ES (1) ES2011577A6 (fr)
FI (1) FI900412A0 (fr)
HK (1) HK42394A (fr)
HU (1) HU204710B (fr)
IL (1) IL90092A (fr)
LV (1) LV10054B (fr)
MA (1) MA21560A1 (fr)
MW (1) MW390A1 (fr)
OA (1) OA09785A (fr)
PH (1) PH26284A (fr)
RU (1) RU2092183C1 (fr)
WO (1) WO1989011294A1 (fr)
YU (1) YU109289A (fr)
ZA (1) ZA893382B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier
JP2732515B2 (ja) * 1990-01-08 1998-03-30 ニカ ヘルス プロダクツ リミテッド リボヌクレアーゼ二量体の製造方法
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
WO2005115477A2 (fr) 2004-04-13 2005-12-08 Quintessence Biosciences, Inc. Conjugues de ribonuclease non naturelle utilises en tant qu'agents cytotoxiques
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
JP2009541333A (ja) * 2006-06-23 2009-11-26 クインテセンス バイオサイエンシーズ インコーポレーティッド 修飾リボヌクレアーゼ
EP2049151A4 (fr) 2006-07-17 2010-03-24 Quintessence Biosciences Inc Méthodes et compositions pour le traitement du cancer
WO2008109401A2 (fr) * 2007-03-02 2008-09-12 Saint Simeon Lda Composition et procédé de traitement du virus de papillome et des sarcoïdes équins
US20100317677A1 (en) * 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
JP2010540681A (ja) * 2007-10-08 2010-12-24 クインテッセンス バイオサイエンシズ，インコーポレーテッド リボヌクレアーゼに基づく治療のための組成物及び方法
BRPI0920743A2 (pt) 2008-10-01 2016-09-20 Quintessence Biosciences Inc ribonucleases terapeuticas
WO2010099182A1 (fr) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Créatine activée et ses précurseurs en tant qu'agents antibactériens, compositions et produits les contenant et leurs utilisations
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
EP2457576B1 (fr) 2010-11-29 2020-07-08 Eurochit Danuta Kruszewska Lactobacillus reuteri pour l'utilisation dans la prophylaxie et le traitement médical et vétérinaire du syndrome métabolique ou des infections.
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
EP2674162A1 (fr) 2012-05-29 2013-12-18 Danuta Kruszewska Nano-produit, comprenant des lactobacillus reuteri dan080, utile dans la prophylaxie, diagnostic et traitement médical et vétérinaire
US20160032413A1 (en) 2012-05-29 2016-02-04 Danuta KRUSZEWSKA Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
WO2014152678A1 (fr) 2013-03-15 2014-09-25 University Of Massachusetts Compositions et procédés d'administration d'agents au système nerveux central
US20170049863A1 (en) * 2014-02-21 2017-02-23 National University Corporation Tokyo University Of Marine Science And Technology Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes
WO2016017784A1 (fr) * 2014-07-31 2016-02-04 キユーピー株式会社 Composition fluide contenant de l'eau, procédé de préparation de celle-ci, lysozyme traité et/ou sel de celui-ci, et son procédé de production
EP3194425A1 (fr) 2014-09-17 2017-07-26 Spogen Biotech Inc. Protéines hybrides, bactéries recombinées et procédés d'utilisation de bactéries recombinées
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
WO2018123821A1 (fr) 2016-12-28 2018-07-05 Dic株式会社 Dispersion et composition d'encre pour jet d'encre, couche de conversion de lumière et élément d'affichage à cristaux liquides utilisant la dispersion
NZ763625A (en) 2017-09-20 2024-07-26 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and exosporium fragments for plant health
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (fr) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
EP0187705A3 (fr) * 1985-01-08 1988-05-11 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines utiles comme agents immunomodulateurs
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier

Also Published As

Publication number Publication date
JPH0649659B2 (ja) 1994-06-29
DK173078B1 (da) 1999-12-20
ES2011577A6 (es) 1990-01-16
MW390A1 (en) 1990-11-14
AU624331B2 (en) 1992-06-11
PH26284A (en) 1992-04-10
YU109289A (en) 1991-08-31
ZA893382B (en) 1991-01-30
HUT54060A (en) 1991-01-28
HU204710B (en) 1992-02-28
BG91270A (bg) 1993-12-24
BG60544B1 (en) 1995-08-28
JPH03504121A (ja) 1991-09-12
CS318089A3 (en) 1992-05-13
HK42394A (en) 1994-05-13
US6099835A (en) 2000-08-08
IL90092A (en) 1995-03-30
CS277030B6 (en) 1992-11-18
WO1989011294A1 (fr) 1989-11-30
EP0380484B1 (fr) 1993-08-18
EP0380484A1 (fr) 1990-08-08
CA1335425C (fr) 1995-05-02
FI900412A0 (fi) 1990-01-25
DK16890A (da) 1990-01-22
ATE93143T1 (de) 1993-09-15
DK16890D0 (da) 1990-01-22
US5466449A (en) 1995-11-14
OA09785A (en) 1994-04-15
AU1940888A (en) 1989-12-12
LV10054B (en) 1995-02-20
HU883981D0 (en) 1990-12-28
US5200182A (en) 1993-04-06
LV10054A (lv) 1994-05-10
RU2092183C1 (ru) 1997-10-10

Similar Documents

Publication Publication Date Title
MA21560A1 (fr) Nouvelles compositions comprenant des enzymes polymerises.
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
CY1107995T1 (el) ΑΝΑΣΤΟΛΗ ΔΡΑΣΤΙΚΟΤΗΤΑΣ p38 ΚΙΝΑΣΗΣ ΧΡΗΣΙΜΟΠΟΙΩΝΤΑΣ ΑΡΥΛ ΚΑΙ ΕΤEPΟΑΡΥΛ ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΤEPΟΚΥΚΛΙΚΕΣ ΟΥΡΙΕΣ
AU5118990A (en) Compositions for the sustained-release of chlorhexidine
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
EE9900428A (et) Köhavastased ravimkoostised
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ATE267198T1 (de) Synthese und anti-hiv und anti-hepatitis virus aktivität von 1,3-oxaselenolan nucleosiden
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
ATE311897T1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
MY106984A (en) Antiviral or antibacterial composition and method of use.
NO158186C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cis-2-(1h-imidazolylmethyl)-3-difluorbenzyloxy-2,3-dihydrofluorbenzo(b)thiofener.
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
IT8348383A0 (it) Enzima simile a pepsina da leucocito umano, procedimento per prepararlo, e composizione terapeutica che lo contiene come ingrediente attivo